pulmonary fibrosis. Archives - The Hippocratic Post

Iron accumulation: a new insight into fibrotic diseases

Posted on December 18, 2023 by Hippocratic Post

Fibrosis is associated with various chronic and life-threatening conditions, including pulmonary fibrosis, liver cirrhosis, kidney disease, and cardiovascular diseases, among others. These conditions collectively contribute to a substantial portion of mortality in developed countries, making fibrotic diseases a critical health problem requiring attention, research, and innovative approaches for diagnosis and treatment. Scientists at IRB Barcelona’s […]

Eucalyptus compound to treat lung fibrosis

Posted on December 20, 2021 by Hippocratic Post

Australian-produced eucalyptus compound effective at treating lung damage in sheep model: University of Melbourne-led research has shown the flavonoid pinocembrin, derived from Australian eucalyptus trees, has strong anti-inflammatory properties and could be safe and effective at treating lung fibrosis in sheep, a large animal model for human lung disease. Pinocembrin, a flavonoid found in several different […]

Scotland: Hope for patients with pulmonary fibrosis

Posted on June 12, 2021 by Hippocratic Post

The Scottish Medicines Consortium (SMC) has announced that the anti-fibrotic medicine nintedanib has been accepted for use by NHS Scotland for the treatment of patients with the lung scarring disease pulmonary fibrosis. Action for Pulmonary Fibrosis (APF) has spearheaded a campaign for patients in Scotland with the support of patients, families and medical experts, to […]

Victory for thousands of terminally ill patients

Posted on May 28, 2021 by Hippocratic Post

Antifibrotic drugs offer hope to thousands of patients who are living with a condition that has a worse outcome than most cancers. · Action for Pulmonary Fibrosis (APF) is delighted to announce their campaign, backed by patients, families and medical experts, to end the inhumane restrictions on life-extending antifibrotic drugs has been successful. · Today […]